Flagship Pioneering Appoints Paul Owen as CEO-Partner and CEO of YourBio Health
YourBio Health and Flagship Pioneering have announced the appointment of Paul Owen as CEO of YourBio Health and CEO-Partner of Flagship Pioneering. Owen brings over 35 years of corporate leadership experience, most recently serving as Board Director and President of Oncodea.
YourBio Health's key product, the Touch-Activated Phlebotomy (TAP®) device, is the first push-button blood collection technology using microneedles for virtually painless blood draws. The technology has been implemented in clinical trials, diagnostic settings, and wellness applications, with millions of blood collections completed since its commercial launch.
The company has established partnerships with biopharmaceutical companies, genetic companies, and academic research hospitals. The announcement also includes concurrent appointments to YourBio's leadership team, adding expertise in medical device product innovation, clinical strategy, and commercialization.
YourBio Health e Flagship Pioneering hanno annunciato la nomina di Paul Owen come CEO di YourBio Health e CEO-Partner di Flagship Pioneering. Owen porta con sé oltre 35 anni di esperienza nella leadership aziendale, avendo recentemente ricoperto il ruolo di Direttore del Consiglio e Presidente di Oncodea.
Il prodotto chiave di YourBio Health, il dispositivo di flebotomia attivato da tocco (TAP®), è la prima tecnologia di raccolta del sangue a pulsante che utilizza microaghi per prelievi di sangue praticamente indolori. La tecnologia è stata implementata in studi clinici, contesti diagnostici e applicazioni di benessere, con milioni di raccolte di sangue completate dalla sua commercializzazione.
L'azienda ha stabilito partnership con aziende biofarmaceutiche, aziende genetiche e ospedali di ricerca accademica. L'annuncio include anche nomine contemporanee nel team di leadership di YourBio, aggiungendo competenze nell'innovazione dei prodotti per dispositivi medici, nella strategia clinica e nella commercializzazione.
YourBio Health y Flagship Pioneering han anunciado el nombramiento de Paul Owen como CEO de YourBio Health y CEO-Partner de Flagship Pioneering. Owen aporta más de 35 años de experiencia en liderazgo corporativo, habiendo servido más recientemente como Director de la Junta y Presidente de Oncodea.
El producto clave de YourBio Health, el dispositivo de flebotomía activado por toque (TAP®), es la primera tecnología de recolección de sangre con botón que utiliza microagujas para extracciones de sangre prácticamente indoloras. La tecnología se ha implementado en ensayos clínicos, entornos de diagnóstico y aplicaciones de bienestar, con millones de recolecciones de sangre completadas desde su lanzamiento comercial.
La empresa ha establecido asociaciones con compañías biofarmacéuticas, compañías genéticas y hospitales de investigación académica. El anuncio también incluye nombramientos simultáneos en el equipo de liderazgo de YourBio, añadiendo experiencia en innovación de productos de dispositivos médicos, estrategia clínica y comercialización.
YourBio Health와 Flagship Pioneering은 Paul Owen을 YourBio Health의 CEO이자 Flagship Pioneering의 CEO-Partner로 임명했다고 발표했습니다. Owen은 최근 Oncodea의 이사 및 회장으로 재직하며 35년 이상의 기업 리더십 경험을 지니고 있습니다.
YourBio Health의 주요 제품인 터치 활성화 채혈 장치(TAP®)는 마이크로바늘을 사용하는 최초의 버튼형 혈액 채취 기술로, 거의 고통 없이 혈액을 채취할 수 있습니다. 이 기술은 임상 시험, 진단 환경 및 웰니스 애플리케이션에 도입되었으며, 상업 출시 이후 수백만 건의 혈액 채취가 완료되었습니다.
회사는 생물 제약 회사, 유전자 회사, 학술 연구 병원과 파트너십을 구축했습니다. 이 발표에는 YourBio의 리더십 팀에 대한 동시 임명도 포함되어 있으며, 의료기기 제품 혁신, 임상 전략 및 상업화에 대한 전문성을 추가하고 있습니다.
YourBio Health et Flagship Pioneering ont annoncé la nomination de Paul Owen en tant que PDG de YourBio Health et PDG-Partner de Flagship Pioneering. Owen apporte plus de 35 ans d'expérience en leadership d'entreprise, ayant récemment occupé le poste de Directeur du Conseil et Président d'Oncodea.
Le produit clé de YourBio Health, le dispositif de phlébotomie activé par toucher (TAP®), est la première technologie de collecte de sang par bouton-poussoir utilisant des microneedles pour des prélèvements sanguins pratiquement indolores. La technologie a été mise en œuvre dans des essais cliniques, des environnements diagnostiques et des applications de bien-être, avec des millions de collectes de sang réalisées depuis son lancement commercial.
L'entreprise a établi des partenariats avec des entreprises biopharmaceutiques, des entreprises génétiques et des hôpitaux de recherche académique. L'annonce comprend également des nominations simultanées dans l'équipe de direction de YourBio, ajoutant une expertise en innovation de produits de dispositifs médicaux, en stratégie clinique et en commercialisation.
YourBio Health und Flagship Pioneering haben die Ernennung von Paul Owen zum CEO von YourBio Health und CEO-Partner von Flagship Pioneering bekannt gegeben. Owen bringt über 35 Jahre Erfahrung in der Unternehmensführung mit, zuletzt als Vorstand und Präsident von Oncodea tätig.
Das Hauptprodukt von YourBio Health, das berührungsgesteuerte Phlebotomie-Gerät (TAP®), ist die erste Knopfdruck-Technologie zur Blutentnahme, die Mikronadeln verwendet und nahezu schmerzfreie Blutentnahmen ermöglicht. Die Technologie wurde in klinischen Studien, diagnostischen Einrichtungen und Wellness-Anwendungen implementiert, mit Millionen von Blutentnahmen, die seit der Markteinführung durchgeführt wurden.
Das Unternehmen hat Partnerschaften mit biopharmazeutischen Unternehmen, genetischen Unternehmen und akademischen Forschungskrankenhäusern aufgebaut. Die Ankündigung umfasst auch gleichzeitige Ernennungen im Führungsteam von YourBio, die Expertise in der Produktinnovation von medizinischen Geräten, klinischer Strategie und Kommerzialisierung hinzufügen.
- TAP® device has proven commercial traction with millions of blood collections completed
- Established partnerships with biopharmaceutical companies and research hospitals
- Strengthened leadership team with medical device and commercialization expertise
- None.
Owen joins to lead new phase of growth for the medical device company in clinical trial, diagnostic, and reference laboratory applications
Owen joins YourBio Health and Flagship after a corporate leadership and strategic planning career spanning more than 35 years. He was most recently Board Director and President of Oncodea, an early cancer detection company, and a Managing Partner for Trusted Health Advisors, overseeing diagnostics, companion diagnostics, population health, and digital health. He has previously held leadership roles across digital health and health care solutions including with imaware™, OneOme, and Mayo Medical Laboratories.
"Paul's strategic vision and leadership will be instrumental as YourBio Health continues its mission to humanize, decentralize, and transform the blood collection process, which we envision serving the entire healthcare industry," said Noubar Afeyan, Ph.D., Founder and CEO of Flagship Pioneering. "We are pleased to welcome him to the Flagship leadership network and look forward to his impact on YourBio Health."
The company's Touch-Activated Phlebotomy (TAP®) device is the first push-button blood collection technology. Using microneedles to achieve virtually painless blood draws, TAP products are used today in clinical trial, diagnostic, and wellness settings and enable easy-to-use and reliable at-home blood collection. The Flagship-founded company has existing partnerships with biopharmaceutical companies, leading genetic companies, and academic research hospitals. Since commercial launch, TAP devices have been used in multiple clinical trials and in millions of blood collections.
"There is enormous potential in making blood collection easier and more accessible to better treat and preempt diseases," said Ignacio Martinez, General Partner, Flagship Pioneering and Executive Chairman, YourBio. "Now is the moment for YourBio to build on the demonstrated utility of its technology, and Paul is the right leader to meet that moment."
"I am pleased to have the chance to lead YourBio Health and collaborate with the exceptional and forward-thinking leadership teams at both companies," said Paul Owen. "Throughout my career, I've seen the challenges created by phlebotomy – the pain, discomfort and logistical challenges for trial sponsors, patients, clinicians and healthcare organizations. I look forward to scaling and growing YourBio so this technology can help eliminate those challenges and deliver a better-quality patient experience."
The company also announced today concurrent appointments to its leadership team, adding medical device product innovation, clinical strategy, and commercialization expertise.
About Paul Owen
Paul Owen brings over 35 years of experience in corporate leadership and strategic planning, with a proven ability to achieve business targets.
Prior to joining YourBio, he served as Board Director and President of Oncodea, an early cancer detection company, and a Managing Partner for Trusted Health Advisors, overseeing diagnostics, companion diagnostics, population health, and digital health. He previously served as President and Interim CEO of imaware™, which provides a digital health platform experience that offers advanced home-based testing and monitoring. Prior, Owen was the Vice Chair – Product, for Global Business Solutions of Mayo Clinic and Global Commercial Leader of Mayo Medical Laboratories.
Owen previously served as Chief Business Officer and COO for Kailos Genetics and CEO of OneOme, an innovator in precision medicine and pharmacogenetics co-founded by Mayo Clinic. While he led OneOme, Fast Company recognized it as one of the top 50 most innovative companies in the world and #2 in biotech. Inc. Magazine awarded it the 2019 MedTech Breakthrough Award for Best Overall Genomics Company. Owen also actively serves as a Board Director and Executive Advisor for a number of life sciences companies.
He received his B.S. from the University of
About Flagship Pioneering
Flagship Pioneering invents and builds bioplatform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than
About YourBio Health
YourBio Health is a medical device company that strives to take the pain out of the blood draw experience with its 'Touch-Activated Phlebotomy' (TAP®), the world's first push-button blood collection technology. TAP products eliminate barriers to blood collection by allowing a capillary blood sample to be collected from any physical location without the pain of a fingerstick or the need for traditional phlebotomy. Backed by the latest science, data management technology, and certified central labs, YourBio Health seeks to revolutionize and humanize the blood collection process serving clinical trials, diagnostic, wellness, and reference laboratory applications. YourBio was founded by Flagship Pioneering in 2011.
Media Contact
View original content to download multimedia:https://www.prnewswire.com/news-releases/flagship-pioneering-appoints-paul-owen-as-ceo-partner-and-ceo-of-yourbio-health-302379939.html
SOURCE Flagship Pioneering
FAQ
What is YourBio Health's TAP® device and how does it work?
How many blood collections have been performed using YourBio Health's TAP® device?
What experience does Paul Owen bring to YourBio Health as the new CEO?
What partnerships does YourBio Health currently have?
